Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1

American Journal of Physiology - Cell Physiology

Volumn 301, Issue 5, 2011, Pages

  Trueblood, Katherine E ^a   Mohr, Susanne ^b   Dubyak, George R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Hyperglycemia; Inflammasome; Purinergic signaling; Sterile inflammation

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; APYRASE; CYCLIC AMP; DIPYRIDAMOLE; FORSKOLIN; GLUCOSE; INOSINE; INTERLEUKIN 1BETA CONVERTING ENZYME; PURINE; PURINERGIC P2X7 RECEPTOR; SURAMIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; ENZYME METABOLISM; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RETINA CELL; SIGNAL TRANSDUCTION;

ADENOSINE A2 RECEPTOR ANTAGONISTS; ADENOSINE DEAMINASE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; APYRASE; CASPASE 1; CELL LINE; DIPYRIDAMOLE; ENZYME INHIBITORS; FORSKOLIN; GLUCOSE; HYPERGLYCEMIA; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; RETINA; SURAMIN;

ANIMALIA; RATTUS;

EID: 80054956566     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00265.2011     Document Type: Article

References (60)

1. Adinolfi E, Cirillo M, Woltersdorf R, Falzoni S, Chiozzi P, Pellegatti P, Callegari MG, Pellegatti P, Sandona D, Markwardt F, Schmalzing G, Di Virgilio F. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J 24: 3393-3404, 2010.
2. Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB. Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164: 170-180, 2011.
3. Almeida MQ, Tsang KM, Cheadle C, Watkins T, Grivel JC, Nesterova M, Goldbach-Mansky R, Stratakis CA. Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors. Hum Mol Genet 20: 165-175, 2011.
4. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183: 787-791, 2009.
5. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25: 397-424, 2006.
6. Ceruti S, Fumagalli M, Villa G, Verderio C, Abbracchio MP. Purinoceptor-mediated calcium signaling in primary neuron-glia trigeminal cultures. Cell Calcium 43: 576-590, 2008.
7. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837, 2011.
8. Chen JL, Merl D, Peterson CW, Wu J, Liu PY, Yin H, Muoio DM, Ayer DE, West M, Chi JT. Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet 6, 2011.
9. Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS. Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 63: 641-683, 2011.
10. Corriden R, Insel PA. Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci Signal 3: re1, 2010.
11. Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20: 1366-1369, 2006.
12. Dubyak GR. Go it alone no more-P2X7 joins the society of heteromeric ATP-gated receptor channels. Mol Pharmacol 72: 1402-1405, 2007.
13. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883, 2006.
14. Francke M, Uhlmann S, Pannicke T, Goczalik I, Uckermann O, Weick M, Hartig W, Wiedemann P, Reichenbach A, Bringmann A. Experimental dispase-induced retinopathy causes up-regulation of P2Y receptor-mediated calcium responses in Muller glial cells. Ophthalmic Res 35: 30-41, 2003.
15. Frank RN. Diabetic retinopathy. N Engl J Med 350: 48-58, 2004.
16. Fredholm BB, AP Ij, Jacobson KA, Linden J, Muller CE. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63: 1-34, 2011.
17. Hamada Y, Fukagawa M. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J Med Sci 53: 53-61, 2007.
18. Hong S, Schwarz N, Brass A, Seman M, Haag F, Koch-Nolte F, Schilling WP, Dubyak GR. Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells. J Immunol 183: 578-592, 2009.
19. Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 11: 201-212, 2011.
20. + release. Am J Physiol Cell Physiol 286: C1100-C1108, 2004.
21. Kahlenberg JM, Lundberg KC, Kertesy SB, Qu Y, Dubyak GR. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J Immunol 175: 7611-7622, 2005.
22. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007: 95103, 2007.
23. Koenen TB, Stienstra R, van Tits LJ, de Graaf J, Stalenhoef AF, Joosten LA, Tack CJ, Netea MG. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 60: 517-524, 2011.
24. Krugel K, Wurm A, Pannicke T, Hollborn M, Karl A, Wiedemann P, Reichenbach A, Kohen L, Bringmann A. Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats. Exp Eye Res 92: 87-93, 2011.
25. Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest Ophthalmol Vis Sci 45: 1553-1561, 2004.
26. Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci 43: 3109-3116, 2002.
27. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232, 2006.
28. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nunez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11: 897-904, 2011.
29. McDermott MF, Tschopp J. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends Mol Med 13: 381-388, 2007.
30. Mohr S, Trueblood, K, Vincent, JA. High glucose-induced caspase-1 activation in retinal müller cells is bi-phasic involving receptor interacting protein 2 (RIP 2) upregulation. In: American Diabetes Association 67th Scientific Sessions. Chicago, IL: Am. Diabetes Assoc., 2007.
31. Mohr S, Xi X, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51: 1172-1179, 2002.
32. Pannicke T, Fischer W, Biedermann B, Schadlich H, Grosche J, Faude F, Wiedemann P, Allgaier C, Illes P, Burnstock G, Reichenbach A. P2X7 receptors in Muller glial cells from the human retina. J Neurosci 20: 5965-5972, 2000.
33. Perrone L, Devi TS, Hosoya K, Terasaki T, Singh LP. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 221: 262-272, 2009.
34. Perrone L, Devi TS, Hosoya KI, Terasaki T, Singh LP. Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy. Cell Death Dis 1: e65, 2011.
35. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27: 813-823, 2004.
36. Prosdocimo DA, Douglas DC, Romani AM, O'Neill WC, Dubyak GR. Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. Am J Physiol Cell Physiol 296: C828-C839, 2009.
37. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol 28: 321-342, 2010.
38. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51: 2241-2248, 2002.
39. Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327: 296-300, 2010.
40. Seil M, El Ouaaliti M, Fontanils U, Etxebarria IG, Pochet S, Dal Moro G, Marino A, Dehaye JP. Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X(7)-KO mice. Purinergic Signal 6: 405-416, 2010.
41. Solini A, Chiozzi P, Morelli A, Adinolfi E, Rizzo R, Baricordi OR, Di Virgilio F. Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes. Arterioscler Thromb Vasc Biol 24: 1240-1245, 2004.
42. Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, van den Berg SA, Rensen PC, Voshol PJ, Fantuzzi G, Hijmans A, Kersten S, Muller M, van den Berg WB, van Rooijen N, Wabitsch M, Kullberg BJ, van der Meer JW, Kanneganti T, Tack CJ, Netea MG. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12: 593-605, 2010.
43. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17: 179-188, 2011.
44. Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 56: 224-230, 2007.
45. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Yreceptor subtypes. Pharmacol Ther 110: 415-432, 2006.
46. Wang X, Wang H, Figueroa BE, Zhang WH, Huo C, Guan Y, Zhang Y, Bruey JM, Reed JC, Friedlander RM. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. J Neurosci 25: 11645-11654, 2005.
47. Ward MM, Jobling AI, Kalloniatis M, Fletcher EL. Glutamate uptake in retinal glial cells during diabetes. Diabetologia 48: 351-360, 2005.
48. Wurm A, Erdmann I, Bringmann A, Reichenbach A, Pannicke T. Expression and function of P2Y receptors on Muller cells of the postnatal rat retina. Glia 57: 1680-1690, 2009.
49. Wurm A, Lipp S, Pannicke T, Linnertz R, Farber K, Wiedemann P, Reichenbach A, Bringmann A. Involvement of A(1) adenosine receptors in osmotic volume regulation of retinal glial cells in mice. Mol Vis 15: 1858-1867, 2009.
50. Wurm A, Lipp S, Pannicke T, Linnertz R, Krugel U, Schulz A, Farber K, Zahn D, Grosse J, Wiedemann P, Chen J, Schoneberg T, Illes P, Reichenbach A, Bringmann A. Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells. J Neurochem 112: 1261-1272, 2011.
51. Wurm A, Pannicke T, Iandiev I, Francke M, Hollborn M, Wiedemann P, Reichenbach A, Osborne NN, Bringmann A. Purinergic signaling involved in Muller cell function in the mammalian retina. Prog Retin Eye Res 2011, ePub ahead of print.
52. Xi X, Gao L, Hatala DA, Smith DG, Codispoti MC, Gong B, Kern TS, Zhang JZ. Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Muller cells. Biochem Biophys Res Commun 326: 548-553, 2005.
53. Yego EC, Mohr S. siah-1 Protein is necessary for high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation and cell death in Muller cells. J Biol Chem 285: 3181-3190, 2011.
54. Yego EC, Vincent JA, Sarthy V, Busik JV, Mohr S. Differential regulation of high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation in Muller cells by IL-1beta and IL-6. Invest Ophthalmol Vis Sci 50: 1920-1928, 2009.
55. Yu FX, Chai TF, He H, Hagen T, Luo Y. Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate. J Biol Chem 285: 25822-25830, 2010.
56. Yu FX, Goh SR, Dai RP, Luo Y. Adenosine-containing molecules amplify glucose signaling and enhance txnip expression. Mol Endocrinol 23: 932-942, 2009.
57. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 40: 401-413, 2003.
58. Zepter K, Haffner A, Soohoo LF, De Luca D, Tang HP, Fisher P, Chavinson J, Elmets CA. Induction of biologically active IL-1 betaconverting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol 159: 6203-6208, 1997.
59. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxininteracting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010.
60. Zipfel GJ, Babcock DJ, Lee JM, Choi DW. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J Neurotrauma 17: 857-869, 2000.